It has been reported (134136) that TGP/paeoniflorin can exert anti-RA effects by inhibiting inflammatory processes, inhibiting lymphocyte activation, inhibiting the proliferation and differentiation of synovial cells, and preventing the formation of new blood vessels and the production of MMPs
FDA approved Resmetirom (a THR- agonist) as the first therapeutic agent for MASH
A sudden change in how the medication affects your appetite, energy, or blood sugar, without any other variable changing, could indicate potency loss
The FDA recently approved a new GLP-1 agonist medication called Mounjaro (tirzepatide) for adults with type 2 diabetes
doi: 10.1093/brain/awy182 149 HuJ.DuanH.ZouJ.DingW.WeiZ.PengQ.et al
It is popular globally and genuinely interesting, but the human clinical evidence varies widely by route and dose so we include it for its antioxidant rationale within the formula rather than as the reason the treatment works